## AMT: American Tower Corporation (REI - XLRE: Real Estate

### Executive Summary

VALUE thesis: PEG 1.33 indicates fundamental undervaluation. Quality metrics strong (ROE 29%).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($175.64)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Fayez Sarofim & Co Purchases 17,961 Shares of American Tower Corporation $AMT**
- Source: MarketBeat | 20251209T110818 | Somewhat-Bullish | Relevance: 99%
-  Fayez Sarofim & Co significantly increased its stake in American Tower Corporation (NYSE:AMT) by 52.8%, purchasing 17,961 additional shares, bringing their total holdings to 51,992 shares valued at approximately $11.49 million. This comes as American Tower reported strong quarterly earnings, beating analyst estimates, and announced a quarterly dividend of $1.70 per share. Several other institutional investors have also adjusted their positions in American Tower, with 92.69% of the stock owned by institutional investors.

**2. Barclays Turns Cautious on American Tower (AMT) Amid EchoStar Risks**
- Source: Insider Monkey | 20251206T194138 | Neutral | Relevance: 99%
-  Barclays downgraded American Tower (AMT) to Equal Weight and lowered its price target to $200 from $203, citing concerns over potential difficulties in collecting rent from EchoStar, as well as issues like reserves and churn impacting growth in 2026. This comes despite American Tower reporting strong Q3 2025 earnings, with revenues of $2.7 billion and a 217% increase in net income. The company also raised its full-year property revenue guidance.

**3. California Public Employees Retirement System Cuts Stock Holdings in American Tower Corporation $AMT**
- Source: MarketBeat | 20251207T200813 | Somewhat-Bullish | Relevance: 99%
- The California Public Employees Retirement System (CalPERS) reduced its stake in American Tower Corporation (NYSE:AMT) by 3.4% in the second quarter, selling nearly 50,000 shares. Despite this, an insider, Director Eugene F. Reilly, significantly increased his holdings by over 4,000% with a substantial purchase. American Tower also surpassed recent earnings expectations and announced its FY 2025 guidance, alongside a quarterly dividend payment.

**4. Epoch Investment Partners Inc. Raises Stock Position in American Tower Corporation $AMT**
- Source: MarketBeat | 20251206T092807 | Somewhat-Bullish | Relevance: 99%
-  Epoch Investment Partners Inc. significantly increased its stake in American Tower Corporation, boosting its holdings by 331.2% to 270,653 shares valued at approximately $59.82 million. This move comes as American Tower topped its recent earnings expectations and provided strong FY2025 guidance. Despite a high dividend payout ratio, the company maintains a "Moderate Buy" consensus rating from analysts.

**5. American Tower Corporation $AMT Stock Holdings Trimmed by State Street Corp**
- Source: MarketBeat | 20251209T131405 | Neutral | Relevance: 99%
-  State Street Corp reduced its stake in American Tower Corporation (NYSE:AMT) by 0.6% in the second quarter, ending with 21,113,680 shares valued at approximately $4.70 billion. Despite this, insider Eugene F. Reilly increased his holdings by purchasing 5,554 shares, and the company reported strong quarterly earnings, beating estimates with EPS of $2.78 and revenue of $2.72 billion. American Tower also declared a $1.70 quarterly dividend.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | Morgan Stanley | $225 | $235 | -4% |
| 2025-12-01 | Barclays | $200 | $203 | -1% |
| 2025-11-17 | Barclays | $203 | $251 | -19% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | Morgan Stanley | main | Overweight |
| 2025-12-01 | Barclays | down | Equal-Weight |
| 2025-11-17 | Barclays | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 1 ($0.99M) |
| Sells | 2 ($0.01M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 13.6% (+1.0%)
- Blackrock Inc.: 9.7% (-0.6%)
- JPMORGAN CHASE & CO: 6.6% (+142.8%)
- State Street Corpora: 4.5% (-0.9%)
- Cohen & Steers Inc.: 2.9% (-2.9%)

### Key Risks

1. Long-term trend broken: trading 10.6% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.33 suggests fair value with growth premium. Forward P/E 26.2x attractive for 37% earnings growth. Quality metrics strong (ROE 29%, margin 28%). Analyst sentiment negative (3 target cuts vs 0 raises). Insider buying signal ($1.0M), management confidence. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $85.8B |
| Beta | 0.92 |
| 52W Range | $172.51 - $234.33 |
| Short Interest | 1.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.33 |
| Forward P/E | 26.2 |
| Current P/E | 35.9 |
| YoY Growth | 36.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -4.1% to -0.4% (+3.7% in 5 days), confirming momentum buildup. Below STRENGTH zone by 4.4pp (needs >4.0% for momentum thesis). MRS_5 turning positive (2.4%) - potential reversal signal. Below SMA200 (0.89x), long-term trend not supportive. RSI neutral at 55.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.43% (CS: 54) | Neutral |
| RSI_14 | 54.8 | Neutral |
| MACD Histogram | 0.49 | Bullish |
| vs SMA20 | 1.016x | Above |
| vs SMA50 | 0.996x | Below |
| vs SMA200 | 0.894x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $183.20
- **Stop Loss:** $175.64 (4.1% risk)
- **Target:** $198.32 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 66
- **Position Value:** $12,091.20
- **Portfolio %:** 12.09%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-02-24 (Est: $1.46)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.65 | $1.82 | +10.1% |
| 2025Q2 | $1.66 | $0.78 | -53.0% |
| 2025Q1 | $1.57 | $1.04 | -33.7% |
| 2024Q4 | $1.98 | $2.62 | +32.0% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*